Heart and Vessels

, Volume 29, Issue 2, pp 171–177 | Cite as

Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry

  • Daisuke Abe
  • Akira Sato
  • Tomoya Hoshi
  • Noriyuki Takeyasu
  • Masako Misaki
  • Mayu Hayashi
  • Kazutaka Aonuma
Original Article


We investigated clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) treated for initial culprit-only or by initial simultaneous treatment of nonculprit lesion with culprit lesion. Optimal management of multivessel disease in STEMI patients treated by primary percutaneous coronary intervention (PCI) is still unclear in the drug-eluting stent era. We compared clinical outcomes of 274 STEMI patients (69.3 ± 11.8 years, 77 % men) in the Ibaraki Cardiovascular Assessment Study registry who underwent initial culprit-only (OCL, n = 220) or initial multivessel PCI of nonculprit lesion with culprit lesion (NCL, n = 54) from April 2007 to August 2010. Major adverse cardiac and cerebrovascular events (MACCE) included all-cause death, myocardial infarction (MI), target-vessel revascularization (TVR), and cerebrovascular accident (CVA). Patients in the NCL group were older and had higher Killip class and lower estimated glomerular filtration rate than those in the OCL group. MI, TVR, CVA, and stent thrombosis were not significantly different between the two groups. Incidences of all-cause death and MACCE were lower in the OCL than in the NCL group (all-cause death: 10.9 % vs 31.5 %, P < 0.05; MACCE: 27.7 % vs 46.2 %, P < 0.05). After adjusting for patient characteristics, NCL remained at significantly higher risk compared with OCL for in-hospital and all-cause death (P = 0.001, respectively), and MACCE were not significantly different (odds ratio 1.95, 95 % confidence interval 0.94–4.08; P = 0.07) between groups. Initial multivessel PCI was associated with significantly increased risk of in-hospital death, all-cause death, and MACCE, which was somewhat attenuated in a multivariable model, but the numerically excessive risk with NCL still persisted.


ST-segment elevation myocardial infarction Percutaneous coronary intervention Outcomes 



We thank the following physicians who participated as investigators in the ICAS registry and who made this work possible: T. Adachi, Y. Eki, T. Enomoto, M. Endou, E. Ojima, K. Obara, Y. Sato, A. Suzuki, S. Suzuki, Y. Noguchi, H. Nishina, Y. Kakefuda, D. Hiraya, H. Higuchi, H. Maeda, K. Nakanishi, Y. Oyake, A. Yamazaki, T. Yamanouchi, I. Yoshida, and S. Watanabe.

Conflict of interest

No conflicts of interest exist.


  1. 1.
    Ishikawa T, Mutoh M, Nakano Y, Endo A, Kubota T, Suzuki T, Nakata K, Murakami A, Miyamoto T, Sakamoto H, Okada H, Imai K, Yoshimura M (2011) Retrospective comparison of clinical and angiographic outcomes after primary stenting using sirolimus-eluting and bare-metal stents in nonrandomized consecutive 568 patients with first ST-segment elevated myocardial infarctions. J Cardiol 57:44–52PubMedCrossRefGoogle Scholar
  2. 2.
    Muller DW, Topol EJ, Elis SG, Sigmon KN, Lee K, Califf RM (1991) Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 121:1042–1049PubMedCrossRefGoogle Scholar
  3. 3.
    Jaski BE, Cohen JD, Trausch J, Marsh DG, Bail GR, Overlie PA, Skowronski EW, Smith SC Jr (1992) Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 124:1427–1433PubMedCrossRefGoogle Scholar
  4. 4.
    Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, Buller CE, Wong SC, Boland J, Dzavik V, Porway M, Bergman G, Hochman JS (2003) Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 42:1380–1386PubMedCrossRefGoogle Scholar
  5. 5.
    Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O’Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113:156–175PubMedCrossRefGoogle Scholar
  6. 6.
    Roe MT, Cura FA, Joski PS, Garcia E, Guetta V, Kereiakes DJ, Zijlstra F, Brodie BR, Grines CL, Ellis SG (2001) Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 88(170–173):A6Google Scholar
  7. 7.
    Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, Emanuela P, Stefano DS, Angelo R, Stefania C, Anna F, Carmelo C, Antonio C, Monzini N, Bonardi MA (2004) Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 6:128–133PubMedGoogle Scholar
  8. 8.
    Song YB, Lee SY, Hahn JY, Choi SH, Choi JH, Lee SH, Hong HP, Park JE, Gwon HC (2012) Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era. Heart Vessels 27:433–442PubMedCrossRefGoogle Scholar
  9. 9.
    Chen Y, Wang C, Yang X, Wang L, Sun Z, Liu H, Chen L (2012) Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels 27:243–249PubMedCrossRefGoogle Scholar
  10. 10.
    Mehran R, Aymong Eve D, Nikolsky Eugenia, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 44:1393–1399PubMedGoogle Scholar
  11. 11.
    Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA (2007) Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297:159–168PubMedCrossRefGoogle Scholar
  12. 12.
    Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O’Neill WW (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343:915–922PubMedCrossRefGoogle Scholar
  13. 13.
    Ambrose JA (2008) In search of the “vulnerable plaque”: can it be localized and will focal regional therapy ever be an option for cardiac prevention? J Am Coll Cardiol 51:1539–1542PubMedCrossRefGoogle Scholar
  14. 14.
    Toma M, Buller CE, Westerhout CM, Fu Y, O’Neill WW, Holmes DR Jr, Hamm CW, Granger CB, Armstrong PW, Investigators APEX-AMI (2010) Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insight from the APEX-AMI trial. Eur Heart J 31:1701–1707PubMedCrossRefGoogle Scholar
  15. 15.
    Corpus RA, House JA, Marso SP, Grantham JA, Huber KC Jr, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford BD (2004) Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 148:493–500PubMedCrossRefGoogle Scholar
  16. 16.
    Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB 3rd (2010) Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 3:22–31PubMedCrossRefGoogle Scholar
  17. 17.
    De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Van de Werf F, Antman EM, Topol EJ (2005) Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293:1759–1765PubMedCrossRefGoogle Scholar
  18. 18.
    De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, Chiariello M, Marino P (2008) Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol 126:37–44PubMedCrossRefGoogle Scholar
  19. 19.
    De Luca G, Gibson CM, Bellandi F, Murphy S, Maioli M, Noc M, Zeymer U, Dudek D, Arntz HR, Zorman S, Gabriel HM, Emre A, Cutlip D, Biondi-Zoccai G, Rakowski T, Gyongyosi M, Marino P, Huber K, van’t Hof AW (2008) Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart 94:1548–1558PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F (2008) Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J 29:3002–3010PubMedCrossRefGoogle Scholar
  21. 21.
    De Luca G, Valgimigli M, Spaulding C, Menichelli M, Brunner-La Rocca HP, van der Hoeven BL, Di Lorenzo E, de Diaz la Llera LS, Pasceri V, Pittl U, Percoco G, Violini R, Stone GW (2009) Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. J Thromb Thrombolysis 28:200–210PubMedCrossRefGoogle Scholar
  22. 22.
    De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U, Violini R, Percoco G, Marino P (2009) Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol 133:213–222PubMedCrossRefGoogle Scholar
  23. 23.
    Bauer T, Möllmann H, Zeymer U, Hochadel M, Nef H, Weidinger F, Zahn R, Hamm CW, Marco J, Gitt AK (2012) Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry. Heart Vessels 27:453–459PubMedCrossRefGoogle Scholar
  24. 24.
    Navarese EP, De Servi S, Buffon A, Suryapranata H, De Luca G (2011) Clinical impact of simultaneous complete revascularization vs culprit only primary angioplasty in patients with ST-elevation myocardial infarction and multivessel disease: a meta-analysis. J Thromb Thrombolysis 31:217–225PubMedCrossRefGoogle Scholar
  25. 25.
    Qarawani D, Nohir M, Abbound M, Hazanov Y, Hasin Y (2008) Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 123:288–292PubMedCrossRefGoogle Scholar
  26. 26.
    Politi L, Squra F, Rossi R, Monopoli D, Guerri E, Leuzzi C, Bursi F, Sangiorgi GM, Modena MG (2010) A randomised trial of target-vessel versus multi-vessel revascularization in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart 96:662–667PubMedCrossRefGoogle Scholar
  27. 27.
    Bangalore S, Kumar S, Poddar KL, Ramasamy S, Rha SR, Faxon DP (2010) Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. Am J Cardiol 107:1300–1310CrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Daisuke Abe
    • 1
  • Akira Sato
    • 2
  • Tomoya Hoshi
    • 2
  • Noriyuki Takeyasu
    • 1
  • Masako Misaki
    • 1
  • Mayu Hayashi
    • 1
  • Kazutaka Aonuma
    • 2
  1. 1.Department of CardiologyIbaraki Prefectural Central HospitalIbarakiJapan
  2. 2.Cardiovascular Division, Faculty of MedicineUniversity of TsukubaTsukubaJapan

Personalised recommendations